Generali (ARZGY) Q3 2024 Earnings Call Highlights: Strong Business Growth Amidst Challenges

Published 2024-11-17, 02:00 a/m
Generali (ARZGY) Q3 2024 Earnings Call Highlights: Strong Business Growth Amidst Challenges
GASI
-

GuruFocus - Release Date: November 15, 2024

For the complete transcript of the earnings call, please refer to the full earnings call transcript.

Positive Points

  • Generali (BIT:GASI) (ARZGY) reported a robust new business margin of 4.9% in the third quarter, aligning with their guidance range of 4.5% to 5%.
  • The company experienced an 11.5% growth in new business volume with protection, contributing over 40% to new business value.
  • Generali (ARZGY) achieved a significant improvement in the undiscounted combined ratio, which decreased to 96.3%, down by 1.4% compared to the previous year.
  • The company maintained a solid net promoter score leadership position, reflecting strong customer relationships and satisfaction.
  • Generali (ARZGY) saw a 6.8% overall growth in annual average premiums across its 10 main markets, with motor line premiums increasing by 7.5%.
Negative Points
  • Generali (ARZGY) faced a higher-than-budgeted impact from natural catastrophes, with losses about 100 basis points higher than expected for the first nine months of 2024.
  • The company anticipates restructuring costs in the fourth quarter, potentially driven by recent acquisitions.
  • Generali (ARZGY) expects a negative impact of around EUR 40 million due to the tax reform under discussion in France.
  • The company is likely to record some impairments on a selected number of real estate exposures.
  • Generali (ARZGY) noted a EUR 100 million negative impact from lower interest rates affecting economic variances.
Q & A Highlights Q: Can you provide more color on the benign frequency and low bodily injury claims in Q3, and how much of this is a quarterly benefit?

A: (Cristiano, Group CFO) The benign frequency and low bodily injury claims are important trends that have been confirmed quarter after quarter. While we caution against projecting this linearly, the improvement in technical profitability is expected to continue. The speed of this improvement will be moderated by our prudent approach to loss picks, but the underlying trends are positive.

Q: Can you unpack the variances in the Life segment, particularly the expected return despite lower rates?

A: (Cristiano, Group CFO) The economic variances in Q3 were around EUR 400 million, driven by positive equity market performance and lower market volatilities, which offset the negative impact of lower interest rates. Operating variances were primarily due to lapses, amounting to over EUR 100 million.

Q: Regarding the investment results, are there non-recurring items similar to Q2?

A: (Cristiano, Group CFO) The non-recurring items in Q3 2024 are not as significant as in Q3 2023. Last year, we had increased hedging costs in Switzerland, which impacted results. This year, the investment results are more stable, with no significant non-recurring items.

Q: Can you update us on pricing versus claims inflation in your main markets?

A: (Cristiano, Group CFO) In the motor segment, average premiums increased by about 7.5%, which is ahead of claims inflation. The earned premium increase is slightly below the average premium increase, indicating embedded improvement. In the accident and health segment, we see high single-digit premium increases, which are ahead of claims inflation.

Q: How do you see the impact of NatCat events on pricing and your strategic outlook?

A: (Cristiano, Group CFO) The NatCat events will likely lead to a continuation of the hardening cycle in personal lines in Europe. We expect to adjust our pricing strategy to account for increased volatility and ensure adequate risk coverage. This will provide room for additional price increases in the coming quarters.

For the complete transcript of the earnings call, please refer to the full earnings call transcript.

This content was originally published on Gurufocus.com

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.